The deal gives Siemens Healthineers access to Neo New Oncology's next-generation sequencing-based assays and technology for tissue and biofluid specimens.
The companies will work together to pursue US Food and Drug Administration clearance for a workflow combining Siemens' sample prep module and Thermo's qPCR instrument.
The scientific products giants are exhibiting their combined workflow next week at the European Congress of Clinical Microbiology and Infectious Disease.
Agilent will pay Enzo $9 million to settle the suit, which involved a US patent issued to Enzo and describing non-porous solid supports for nucleic acids.
NEW YORK (GenomeWeb) – With the launch last year of two US Food and Drug Administration-cleared mass spec microbiology platforms, microbe identification has emerged as one of clinical proteomics' most prominent success stories.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
